Cargando…
Immunotherapeutic organoids: A new approach to cancer treatment
Therapeutic monoclonal antibodies have revolutionized the treatment of cancer and other diseases. However, several limitations of antibody-based treatments, such as the cost of therapy and the achievement of sustained plasma levels, should be still addressed for their widespread use as therapeutics....
Autores principales: | Compte, Marta, Nuñez-Prado, Natalia, Sanz, Laura, Álvarez-Vallina, Luís |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732323/ https://www.ncbi.nlm.nih.gov/pubmed/23507921 http://dx.doi.org/10.4161/biom.23897 |
Ejemplares similares
-
Role of nucleotide‐binding oligomerization domain 1 (NOD1) in pericyte‐mediated vascular inflammation
por: Navarro, Rocío, et al.
Publicado: (2016) -
Functional comparison of single-chain and two-chain anti-CD3-based bispecific antibodies in gene immunotherapy applications
por: Compte, Marta, et al.
Publicado: (2014) -
When three is not a crowd: trispecific antibodies for enhanced cancer immunotherapy
por: Tapia-Galisteo, Antonio, et al.
Publicado: (2023) -
Efficient production of single-chain fragment variable-based N-terminal trimerbodies in Pichia pastoris
por: Blanco-Toribio, Ana, et al.
Publicado: (2014) -
Immune Regulation by Pericytes: Modulating Innate and Adaptive Immunity
por: Navarro, Rocío, et al.
Publicado: (2016)